cialis skin cancer lawsuit

Cialis Skin Cancer

If you or a loved one have suffered adverse effects after taking the drug Cialis, you may be eligible for financial compensation.

Cialis, a drug also known as tadalafil used to treat benign prostatic hyperplasia (noncancerous increase in the size of the prostate) and erectile dysfunction, has recently been linked to the development of skin cancer in patients using the drug. It has also been prescribed to treat pulmonary arterial hypertension.

Cialis’ mechanism of action is to inhibit blood flow to the penis by an enzyme known as a PDE5 inhibitor. Various studies have found that PDE5 inhibitors can lead to increased tumor growth. Researchers have also found that users of certain PDE5 inhibitors are up to 84 percent more likely to develop invasive or aggressive melanoma.

The drug is manufactured by Eli Lilly and Co. and received FDA approval in 2003 for use as a once daily pill. Its newfound connection to melanoma has already resulted in a number of lawsuits. The plaintiffs are alleging fraudulent misrepresentation, defective design, negligence and failure to properly test the drug and warn patients of the potential adverse effects. Additionally, they claim that the manufacturers should have known that Cialis’ mechanism of action posed an increased risk of melanoma.

If you or someone you know took Cialis and developed melanoma, the attorneys at Burke Harvey are ready to help you understand your legal rights.